Retinal Disorders and Innovative Therapies

Retinal disorders, including diabetic retinopathy, age-related macular degeneration, and retinal detachment, present significant challenges due to their complex pathophysiology and risk of irreversible vision loss. Early detection using fundus photography, optical coherence tomography, and fluorescein angiography is critical for timely intervention. Current treatment strategies include anti-vascular endothelial growth factor therapy, corticosteroid injections, laser photocoagulation, and advanced vitreoretinal surgeries. Challenges persist in managing chronic and progressive retinal diseases, improving treatment adherence, and preventing systemic complications. Artificial intelligence algorithms are increasingly applied to retinal imaging for automated diagnosis, disease progression prediction, and personalized treatment planning. Nanotechnology-based drug delivery systems and gene therapy approaches are emerging as promising tools for targeted intervention and retinal regeneration. Regulatory compliance ensures the safety and efficacy of novel therapies, including biologics and medical devices. Future trends focus on integrating imaging, AI, and advanced therapeutics to improve early detection, enhance visual outcomes, and reduce the global burden of retinal diseases. Research in retinal neuroprotection, stem cell therapies, and personalized medicine is poised to transform retinal care in the coming decade.

    Related Conference of Retinal Disorders and Innovative Therapies

    January 12-13, 2026

    26th Global Ophthalmologists Annual Meeting

    London, UK
    April 20-21, 2026

    3rd International Conference on Ophthalmology

    Barcelona, Spain
    May 07-08, 2026

    7th International Conference on Optometry

    Paris, France
    May 25-26, 2026

    10th World Congress on Eye and Vision

    Madrid, Spain

    Retinal Disorders and Innovative Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in